about
The role of magnetic resonance imaging in the diagnosis and management of prostate cancerInitial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancerSurvival gains needed to offset persistent adverse treatment effects in localised prostate cancerAssessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments.Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.Computational imaging reveals shape differences between normal and malignant prostates on MRI.High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.Informed prostate cancer risk-adjusted testing: a new paradigm.A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.Adverse effects of androgen-deprivation therapy in prostate cancer and their management.Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe approach to reduce over-treatment.Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.Focal irreversible electroporation as primary treatment for localized prostate cancer.The impact of (68)Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.Enhancing active surveillance of prostate cancer: the potential of exercise medicine.Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.Robot-assisted laparoscopic prostatectomy: analysis of an experienced open surgeon's learning curve after 300 procedures.A novel method of bladder neck imbrication to improve early urinary continence following robotic-assisted radical prostatectomy.Outcomes of transperineal template-guided prostate biopsy in 409 patients.Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases.Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer.Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy.Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve-Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases.Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.Reply to Patrick H. Tuliao and Koon Ho Rha's letter to the editor re: James E. Thompson, Sam Egger, Maret Böhm, et al. Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curProspective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
P50
Q26849794-754585C0-BAAD-4F69-B80B-ED502E320958Q34490212-4CFA4008-8EB6-44A4-8A65-4EABAD74FBC2Q35883123-B0766F79-7189-4DC5-92E6-41C3F884C0E0Q36946259-A150F007-F7B4-4413-A21B-275C7F49CA3BQ37125439-9F38A482-AB5A-4AD1-A200-ABB733EF226EQ37444820-67BB1AFB-5309-4EC3-A925-F4C5FF41AB1FQ37538185-6E042388-CE5B-4DBB-8D73-01618386BC95Q37618298-B8A6E63E-839C-4AC4-B599-941CB7E4EA76Q37944906-B1BA3A4B-91D2-478C-AE7C-6516EA258B07Q38063556-4A43B811-AA8A-4874-90A7-4819DC4827F4Q38167489-E314FC09-B250-4501-B2C4-7842BFF29B69Q38261253-14AD174D-8CD6-484B-A8EB-03CF57D9F30CQ38568583-CC1504CD-007B-451C-B4CE-42776F1511E0Q38611750-A1D1504B-04B8-46A5-84D7-883F54F9DF0AQ38630336-E0E4790D-141A-4CBB-AE31-AE1E8F4CE5CAQ38711300-62BD89CD-0D31-4AAB-B651-B3AB4B70481FQ38765391-D67F7588-7E90-427F-94BB-48B1D016462CQ38858888-EF61FF3F-E314-49AE-86BE-030B7A965E4DQ38957244-D26E1433-983A-4536-99A1-0B008D96E54BQ39042948-9B0F4932-9CFE-4083-B4F3-C5FE44FF22FAQ39390030-F1F48502-28C2-42F5-9AEE-4C9EA9F172A5Q39900411-E50147F1-BBB3-4317-95A8-00B94245733CQ40102454-7EDFB5A4-C3D4-4FE2-A906-529578AA33E9Q40170568-62CF929A-5BEB-435C-A037-0BC52C563139Q40327460-4D79218F-6C46-4561-ACB1-A0EC977D65F8Q40440753-226CEC16-B0A9-4522-A002-F44165DAA897Q40541815-6ACE3D5D-E814-473F-BD9F-161E344F986AQ42630766-3C3EFED2-DD8E-4843-9ABC-9AE72EA603AEQ43527973-D19E85DB-BEF6-4DA7-BB02-505A7E588C57Q43607238-FC9B18E8-E64E-414E-A70D-CCF0F0E2A819Q44435099-B371E584-5C4E-4248-9164-99109DAE9333Q45750299-B5F244D4-F407-4497-A601-A21D3102DEA0Q45769213-3DBB9F3E-282A-4AF8-A69D-8BF8B39FF6E6Q46392395-827BA425-4E3A-429C-A096-58F6096154F9Q47256842-A79AD248-1D0B-46BC-9FE7-FDB135FC14F0Q47575119-5EAC75D9-50F3-4A80-95F0-7FBE437DB73DQ47658667-23F40044-AB3F-4B5E-BF15-4100D2E69D16Q48023733-066FB720-A611-4970-99AF-C37387FEB804Q48085721-FFA6D61E-DAAC-4045-9B2D-27F9FE2A6F78Q48227663-5B2A332C-168C-4A4B-A57D-E407DB65510D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0934-0656
@en
name
Phillip D Stricker
@ast
Phillip D Stricker
@en
Phillip D Stricker
@nl
type
label
Phillip D Stricker
@ast
Phillip D Stricker
@en
Phillip D Stricker
@nl
altLabel
Phillip Stricker
@en
prefLabel
Phillip D Stricker
@ast
Phillip D Stricker
@en
Phillip D Stricker
@nl
P108
P106
P31
P496
0000-0002-0934-0656